Schmidt Steffen, Bethge Christoph, Förster Michael H, Schäfer Michael
Klinik für Anaesthesiologie und operative Intensivmedizin, Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin, Germany.
Clin J Pain. 2007 Sep;23(7):605-11. doi: 10.1097/AJP.0b013e318122d1e4.
This clinical study tested the hypothesis whether intraoperative high versus low dose of intravenous remifentanil resulted in postoperatively increased pain sensitivity to painful cold or pressure stimulation in eye surgery patients without significant postoperative pain.
Forty-two minor eye surgery patients were randomized to receive intraoperative high (0.4 microg/kg/min) or low (0.1 microg/kg/min) dose of intravenous remifentanil plus isoflurane over an average period of 70 minutes. Pain assessment at the surgical site, postoperative versus preoperative baseline measurements by the cold as well as the pressor test, sedation score, and withdrawal signs were evaluated 30 and 90 minutes after stop of remifentanil infusion. Patients with pain at the surgical site were excluded.
Pressure pain tolerance thresholds at the palmar carpus of the right hand were significantly decreased in these patients after cessation of intraoperative high but not low dose of IV remifentanil. However, withdrawal latencies to cold stimulation were not significantly altered. Isoflurane concentrations were slightly higher in patients receiving the low dose of remifentanil, however, there were no significant differences in length of anesthesia and postoperative sedation. Signs of withdrawal were not observed.
After high dose intravenous remifentanil our results show signs of a reduced tolerance to painful pressure but not cold stimuli distant to the surgical field. Although clinically relevant surgical pain was not reported in these patients, the demonstrated induction of hyperalgesia to painful pressure stimuli suggests a general effect in the central nervous system.
本临床研究检验了以下假设,即在无明显术后疼痛的眼科手术患者中,术中静脉注射高剂量与低剂量瑞芬太尼是否会导致术后对冷痛或压力刺激的疼痛敏感性增加。
42例眼科小手术患者被随机分为两组,在平均70分钟的时间内分别接受术中高剂量(0.4微克/千克/分钟)或低剂量(0.1微克/千克/分钟)静脉注射瑞芬太尼加异氟烷。在停止输注瑞芬太尼30分钟和90分钟后,通过冷刺激和压力测试评估手术部位的疼痛、术后与术前基线测量值、镇静评分和退缩体征。排除手术部位有疼痛的患者。
在停止术中高剂量而非低剂量静脉注射瑞芬太尼后,这些患者右手掌腕部的压力痛耐受阈值显著降低。然而,对冷刺激的退缩潜伏期没有显著改变。接受低剂量瑞芬太尼的患者异氟烷浓度略高,然而,麻醉时间和术后镇静方面没有显著差异。未观察到退缩体征。
在静脉注射高剂量瑞芬太尼后,我们的结果显示对疼痛压力的耐受性降低,但对手术区域以外的冷刺激耐受性未降低。尽管这些患者未报告有临床相关的手术疼痛,但对疼痛压力刺激的痛觉过敏诱导表明对中枢神经系统有普遍影响。